Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety, Tolerability, PK/PD of TAK-906 in Japanese Healthy Males
jRCT2080223605Phase 1Completed
- Sponsor
- Takeda
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in gastrointestinal conditions comparing TAK-906 with Placebo (2 arms). Primary endpoints: Safety and tolerability of single and multiple doses of TAK-906, Pharmacokinetics of TAK-906 and 1 more. Started Aug 2017; status: completed.
02
Drugs
trazpiroben
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on jRCT2080223605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223605.